Scott Wolchko Net Worth & Insider Trades
Scott Wolchko - President and CEO, Fate Therapeutics Inc
What is Scott Wolchko's Net Worth?
The current estimated net worth of Fate Therapeutics Inc's President and CEO, Scott Wolchko, is estimated to be about $51.73M . Scott Wolchko owns about 385,639 units of Fate Therapeutics Inc common stock. In the last 9 years at Fate Therapeutics Inc, Scott Wolchko has sold an estimated value of $49.2M worth.
What is Scott Wolchko's Past Insider Trading?
Scott Wolchko's largest purchase order was 60,000 units , worth over $253.91K on November 16, 2020. Scott Wolchko's largest sale order was 69,407 units , worth over $8.07M on January 12, 2021. In total, Scott Wolchko has made about 41 transactions over 9 years of their time at Fate Therapeutics Inc. Scott Wolchko usually trades in January, with the busiest year in 2021. The most recent transaction was a sale order of 45,907 units , worth over $240.55K on January 11, 2023.
Scott Wolchko
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
What was Scott Wolchko's Salary in 2020?
As President and CEO of Fate Therapeutics Inc, Scott Wolchko has a total base salary of $570,000 . Scott Wolchko received compensation valued at about $5,600,167 in 2020 after becoming President and CEO. The vast majority of their compensation came in the form of stock awards of $1,451,340 , option awards of $3,222,577 , other earnings, plans or compensations of $356,250 , and
What is Scott Wolchko's' Mailing Address?
- Mailing address is C/o Fate Therapeutics, Inc. 3535 General Atomics Court, Suite 200 San Diego CA 92121 CA
Fate Therapeutics Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
---|---|---|---|---|---|---|---|---|
J. Scott Wolchko | 2020 | $570,000 | - | $1,451,340 | $3,222,577 | $356,250 | - | $5,600,167 |
J. Scott Wolchko | 2019 | $540,000 | - | $4,137,500 | $5,732,955 | $310,500 | - | $10,720,955 |
J. Scott Wolchko | 2018 | $516,000 | - | - | $2,756,998 | $258,000 | - | $3,530,998 |
Edward J. Dulac III | 2020 | $142,500 | $137,917 | $1,420,800 | $3,786,529 | $75,833 | $120,000 | $5,683,579 |
Bahram Valamehr, Ph.D. | 2020 | $390,000 | - | $549,750 | $1,324,347 | $195,000 | - | $2,459,097 |
Bahram Valamehr, Ph.D. | 2019 | $375,000 | - | $744,750 | $1,547,898 | $150,938 | - | $2,818,586 |
Bahram Valamehr, Ph.D. | 2018 | $321,865 | - | - | $2,138,235 | $117,250 | - | $2,577,350 |
Cindy R. Tahl, J.D. | 2020 | $390,000 | - | $549,750 | $1,324,347 | $195,000 | - | $2,459,097 |
Cindy R. Tahl, J.D. | 2019 | $375,000 | - | $744,750 | $1,547,898 | $150,938 | - | $2,818,586 |
Cindy R. Tahl, J.D. | 2018 | $350,000 | - | - | $906,465 | $122,500 | - | $1,378,965 |
Daniel D. Shoemaker, Ph.D. | 2020 | $390,000 | - | $549,750 | $1,324,347 | $195,000 | - | $2,459,097 |
Daniel D. Shoemaker, Ph.D. | 2019 | $375,000 | - | $744,750 | $1,547,898 | $150,938 | - | $2,818,586 |
Daniel D. Shoemaker, Ph.D. | 2018 | $365,000 | - | - | $842,338 | $127,750 | - | $1,335,088 |
No matching records found |
Source: https://www.sec.gov/Archives/edgar/data/1434316/000119312521124699/d85377ddef14a.htm
What are Fate Therapeutics Inc's Past Insider Trades?
Fate Therapeutics Inc's most recent insider trade came on April 21, 2023 by Redmile Group Llc and Jeremy Green who bought 276,639 units worth $1.71M . In the last 10 years, insiders at Fate Therapeutics Inc have sold an estimated value of $160.84M and bought an estimated value of $205.58M worth of shares. Insider trading is most common in January, with the busiest year in 2021. The most active traders at the company are Scott Wolchko, President and CEO, Cindy Tahl, General Counsel and Secretary, and Bahram Valamehr, Chief R&D Officer .
FATE THERAPEUTICS INC Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |